Today, the EVP, Corporate Development of Cambrex Corp (NYSE: CBM), Gregory Sargen, sold shares of CBM for $3.34M.
In addition to Gregory Sargen, one other CBM executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cambrex Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $141 million and quarterly net profit of $24.06 million. In comparison, last year the company earned revenue of $105 million and had a net profit of $19.87 million. CBM’s market cap is $1.61B and the company has a P/E ratio of 15.33. Currently, Cambrex Corp has an average volume of 335.9K.
The insider sentiment on Cambrex Corp has been positive according to 25 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Gregory Sargen’s trades have generated a -30.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies.
